Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sheri L Shamblin

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Trends in Biotechnology|October 25, 2021
Osmotic-controlled release oral tablets: technology and functional insightsKenneth S Ogueri, Sheri L Shamblin
The Journal of Pharmacy and Pharmacology|August 28, 2002
Polyamorphism: a pharmaceutical science perspectiveBruno C Hancock, Evgenyi Y Shalaev, Sheri L Shamblin
Pharmaceutical Research|August 31, 2006
Coupling between chemical reactivity and structural relaxation in pharmaceutical glassesSheri L Shamblin, Bruno C Hancock, Michael J Pikal
Pharmaceutical Research|August 26, 2006
Theoretical and practical approaches for prediction of drug-polymer miscibility and solubilityPatrick J Marsac, Sheri L Shamblin, Lynne S Taylor
Journal of Pharmaceutical Sciences|November 15, 2007
Spontaneous crystallinity loss of drugs in the disordered regions of poly(ethylene oxide) in the presence of waterPatrick J Marsac, Daniel P Romary, Sheri L Shamblin, et al.
Molecular Pharmaceutics|December 5, 2017
Impact of Solid-State Form on the Disproportionation of Miconazole MesylateMitulkumar A Patel, Suman Luthra, Sheri L Shamblin, et al.
International Journal of Pharmaceutics|May 18, 2018
Effect of excipient properties, water activity, and water content on the disproportionation of a pharmaceutical saltMitulkumar A Patel, Suman Luthra, Sheri L Shamblin, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|July 2, 2015
Pharmacoscintigraphy studies to assess the feasibility of a controlled release formulation of ziprasidoneAvinash G Thombre, Sheri L Shamblin, Bimal K Malhotra, et al.
Pharmaceutical Research|March 21, 2007
Improved protocol and data analysis for accelerated shelf-life estimation of solid dosage formsKenneth C Waterman, Anthony J Carella, Michael J Gumkowski, et al.
International Journal of Pharmaceutics|December 12, 2013
Impact of sertraline salt form on the oxidative stability in powder blendsYi-Ling Hsieh, Weili Yu, Yanqiao Xiang, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Trends in Biotechnology|October 25, 2021
Osmotic-controlled release oral tablets: technology and functional insightsKenneth S Ogueri, Sheri L Shamblin
The Journal of Pharmacy and Pharmacology|August 28, 2002
Polyamorphism: a pharmaceutical science perspectiveBruno C Hancock, Evgenyi Y Shalaev, Sheri L Shamblin
Pharmaceutical Research|August 31, 2006
Coupling between chemical reactivity and structural relaxation in pharmaceutical glassesSheri L Shamblin, Bruno C Hancock, Michael J Pikal
Pharmaceutical Research|August 26, 2006
Theoretical and practical approaches for prediction of drug-polymer miscibility and solubilityPatrick J Marsac, Sheri L Shamblin, Lynne S Taylor
Journal of Pharmaceutical Sciences|November 15, 2007
Spontaneous crystallinity loss of drugs in the disordered regions of poly(ethylene oxide) in the presence of waterPatrick J Marsac, Daniel P Romary, Sheri L Shamblin, et al.
Molecular Pharmaceutics|December 5, 2017
Impact of Solid-State Form on the Disproportionation of Miconazole MesylateMitulkumar A Patel, Suman Luthra, Sheri L Shamblin, et al.
International Journal of Pharmaceutics|May 18, 2018
Effect of excipient properties, water activity, and water content on the disproportionation of a pharmaceutical saltMitulkumar A Patel, Suman Luthra, Sheri L Shamblin, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|July 2, 2015
Pharmacoscintigraphy studies to assess the feasibility of a controlled release formulation of ziprasidoneAvinash G Thombre, Sheri L Shamblin, Bimal K Malhotra, et al.
Pharmaceutical Research|March 21, 2007
Improved protocol and data analysis for accelerated shelf-life estimation of solid dosage formsKenneth C Waterman, Anthony J Carella, Michael J Gumkowski, et al.
International Journal of Pharmaceutics|December 12, 2013
Impact of sertraline salt form on the oxidative stability in powder blendsYi-Ling Hsieh, Weili Yu, Yanqiao Xiang, et al.
Pageof 2